Clinical Trial Update: Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating nutrigenetic response to omega-3 fatty acids in individuals with obesity and asthma; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Obesity

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Asthma, Obesity | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-09-08